20% Off | Aarkstore.com || Wilms tumor (nephroblastoma) – pipeline review, h2 2012

1. You can also request for sample page of above
mention reports on sample@aarkstore.com

2. Pages : 33
PDF - $ 2000 | Site Licence - $ 4000 $ | Enterprise License - $
6000 |
20% Off on above 1000$ Reports
25% off on purchase of 2 reports and 30% on purchase of
3 or more reports.
Discount till 31st Dec. 2012.

3. Summary
Global Markets Direct’s, Wilms Tumor (Nephroblastoma) - Pipeline Review,
H2 2012, provides an overview of the indication’s therapeutic pipeline. This
report provides information on the therapeutic development for Wilms
Tumor (Nephroblastoma), complete with latest updates, and special
features on late-stage and discontinued projects. It also reviews key players
involved in the therapeutic development for Wilms Tumor
(Nephroblastoma). Wilms Tumor (Nephroblastoma) - Pipeline Review, Half
Year is built using data and information sourced from Global Markets
Direct’s proprietary databases, Company/University websites, SEC filings,
investor presentations and featured press releases from
company/university sites and industry-specific third party sources, put
together by Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on
the availability and relevance of data for the indicated disease.

4. Scope
- A snapshot of the global therapeutic scenario for Wilms Tumor
(Nephroblastoma).
- A review of the Wilms Tumor (Nephroblastoma) products under development
by companies and universities/research institutes based on information derived
from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined
therapeutics.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under
development for Wilms Tumor (Nephroblastoma).
- Identify emerging players with potentially strong product portfolio and design
effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most
promising pipeline.

5. Table of Contents :
List of Tables 3
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Wilms Tumor (Nephroblastoma) Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Wilms Tumor (Nephroblastoma) 7
Wilms Tumor (Nephroblastoma) Therapeutics under Investigation by
Universities/Institutes 9
Late Stage Products 11
Comparative Analysis 11
Mid Clinical Stage Products 12
Comparative Analysis 12
Early Clinical Stage Products 13
Comparative Analysis 13
Wilms Tumor (Nephroblastoma) Therapeutics – Products under
Investigation by Universities/Institutes 14
Wilms Tumor (Nephroblastoma) – Therapeutics Assessment 15……………

6. Please follow link if you want More Related
Reports :
Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline
Review, H2 2012&PubId=&pagenum=1

7. Related Reports:
Skin And Skin Structure Infections (SSSI) – Pipeline Review, H2 2012
Wilms Tumor (Nephroblastoma) – Pipeline Review, H2 2012
Haemophilus Influenzae Type b Infections – Pipeline Review, H2 2012
Secondary Progressive Multiple Sclerosis (SPMS) – Pipeline Review, H2
2012
Ahn-Gook Pharmaceutical Co., Ltd. – Product Pipeline Review – 2012
Ataxia – Pipeline Review, H2 2012
Enterovirus Infections – Pipeline Review, H2 2012
Biliary Tumor – Pipeline Review, H2 2012
Pemphigus – Pipeline Review, H2 2012
Spinal Stenosis – Pipeline Review, H2 2012 Brain Ischemia – Pipeline
Review, H2 2012

8. For More details about above & other
Reports plz contact :
Lavanya
Aarkstore.com
Contact: Marketing team Mob.No.918149852585
Email: enquiry@aarkstore.com ,
discount@aarkstore.com
URL: http://www.aarkstore.com
http://in.linkedin.com/in/aarkstore
http://www.facebook.com/aarkstore